These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11989055)

  • 21. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
    Lindgren P; Lindström J; Tuomilehto J; Uusitupa M; Peltonen M; Jönsson B; de Faire U; Hellénius ML;
    Int J Technol Assess Health Care; 2007; 23(2):177-83. PubMed ID: 17493303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
    Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
    Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
    Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
    Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for diabetes in general practice. Population screening for diabetes is cost effective.
    Higson N
    BMJ; 2002 Feb; 324(7334):426. PubMed ID: 11855395
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening for Type 2 diabetes--should it be now?
    Borch-Johnsen K; Lauritzen T; Glümer C; Sandbaek A
    Diabet Med; 2003 Mar; 20(3):175-81. PubMed ID: 12675659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we screen for type 2 diabetes: Yes.
    Khunti K; Davies M
    BMJ; 2012 Jul; 345():e4514. PubMed ID: 22777029
    [No Abstract]   [Full Text] [Related]  

  • 28. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening.
    Lauritzen T; Griffin S; Borch-Johnsen K; Wareham NJ; Wolffenbuttel BH; Rutten G;
    Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S6-11. PubMed ID: 11063279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Type 2 diabetes in Denmark].
    Beck-Nielsen H; Henriksen JE
    Ugeskr Laeger; 2012 Sep; 174(37):2132-8. PubMed ID: 22971291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should we still screen for type 2 diabetes after ADDITION-Cambridge? A low-income world perspective.
    Choukem SP; Mbanya JC
    Diabetes Res Clin Pract; 2013 May; 100(2):282-4. PubMed ID: 23462215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Screening. What documentation should be required?].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(2):148-52. PubMed ID: 11831074
    [No Abstract]   [Full Text] [Related]  

  • 32. Should diabetes retinal screening intervals change?
    Leese GP
    Diabet Med; 2013 Jan; 30(1):43-5. PubMed ID: 22823411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comments on type 2 diabetes screening and treatment.
    Konrad G
    Am Fam Physician; 2000 Jan; 61(1):48-9; author reply 49-50. PubMed ID: 10643949
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening for type 2 diabetes.
    Kessel E
    JAMA; 1999 Jun; 281(21):1987-8. PubMed ID: 10359383
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis & commentary: Global prevention and control of type 2 diabetes will require paradigm shifts in policies within and among countries.
    Narayan KM; Echouffo-Tcheugui JB; Mohan V; Ali MK
    Health Aff (Millwood); 2012 Jan; 31(1):84-92. PubMed ID: 22232098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to handle the question of screening in diabetes?].
    Nilsson P; Attvall S
    Lakartidningen; 1997 Oct; 94(41):3595. PubMed ID: 9411100
    [No Abstract]   [Full Text] [Related]  

  • 37. Screening for non-insulin-dependent diabetes mellitus: where to draw the line?
    de Courten M; Zimmet P
    Diabet Med; 1997 Feb; 14(2):95-8. PubMed ID: 9047085
    [No Abstract]   [Full Text] [Related]  

  • 38. [Screening of gestational diabetes. An economical assessment of two models].
    Wølner-Hanssen P
    Lakartidningen; 1995 May; 92(20):2085-6, 2089-90, 2093. PubMed ID: 7760595
    [No Abstract]   [Full Text] [Related]  

  • 39. [General health checks and diabetes screening has no effect].
    Krogsbøll LT; Jørgensen KJ; Gøtzsche PC
    Ugeskr Laeger; 2012 Dec; 174(50):3203; author reply 3200. PubMed ID: 23373075
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of non-insulin-dependent diabetes mellitus].
    Moltke A
    Ugeskr Laeger; 1997 May; 159(21):3187-9. PubMed ID: 9199009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.